EE461 An Italian Real-World Analysis of Economic Impact in Patients with Hypercholesterolemia Treated with Rosuvastatin/Ezetimibe as Free Vs Single-Pill Combination

This real-world analysis evaluated clinical characteristics and economic impact for the Italian National Health System in patients receiving rosuvastatin/ezetimibe (ROS/EZE) as free (FC) vs single-pill combination (SPC).

Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: L. Degli Esposti, L. Perez, M. Dovizio, C. Veronesi, A. Zambon, E. Liberopoulos Source Type: research